[
  {
    "ts": null,
    "headline": "Insights Into Abbott (ABT) Q4: Wall Street Projections for Key Metrics",
    "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.",
    "url": "https://finnhub.io/api/news?id=fc95544b362c5b2b7b57db48fe157e156d2bb09ebb27036f4528d6c090c1295d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768572907,
      "headline": "Insights Into Abbott (ABT) Q4: Wall Street Projections for Key Metrics",
      "id": 138152571,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.",
      "url": "https://finnhub.io/api/news?id=fc95544b362c5b2b7b57db48fe157e156d2bb09ebb27036f4528d6c090c1295d"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Medtech CEO says conference’s appeal in decline",
    "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
    "url": "https://finnhub.io/api/news?id=b99089234609860ffab74c5af5d6e2685b689747f4dd440399c2ae3962327bf4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768566643,
      "headline": "JPM26: Medtech CEO says conference’s appeal in decline",
      "id": 138151699,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
      "url": "https://finnhub.io/api/news?id=b99089234609860ffab74c5af5d6e2685b689747f4dd440399c2ae3962327bf4"
    }
  },
  {
    "ts": null,
    "headline": "TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories",
    "summary": "A Missouri jury awarded damages following claims related to infant formula and necrotizing enterocolitis (NEC), according to court proceedings. ST. LOUIS, MO / ACCESS Newswire / January 16, 2026 / TorHoerman Law, a national injury litigation law firm, ...",
    "url": "https://finnhub.io/api/news?id=1e446ace1f3361e832b13267ec8a0b0535502a26c6396b25abef3887e88e042c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768565700,
      "headline": "TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories",
      "id": 138151766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "A Missouri jury awarded damages following claims related to infant formula and necrotizing enterocolitis (NEC), according to court proceedings. ST. LOUIS, MO / ACCESS Newswire / January 16, 2026 / TorHoerman Law, a national injury litigation law firm, ...",
      "url": "https://finnhub.io/api/news?id=1e446ace1f3361e832b13267ec8a0b0535502a26c6396b25abef3887e88e042c"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Consider Right Now and 2 We Find Risky",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 21.1% gain over the past six months, beating the S&P 500 by 10.6 percentage points.",
    "url": "https://finnhub.io/api/news?id=4531e230f1d47a798028210d43fb68cdeb4990b6a6ddc828cbdc3929e77696ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768538208,
      "headline": "1 Healthcare Stock to Consider Right Now and 2 We Find Risky",
      "id": 138151767,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 21.1% gain over the past six months, beating the S&P 500 by 10.6 percentage points.",
      "url": "https://finnhub.io/api/news?id=4531e230f1d47a798028210d43fb68cdeb4990b6a6ddc828cbdc3929e77696ce"
    }
  }
]